WHO ICTRP trial
A study about immunogenicity and safety of Phase 3 and 4 immunization with…
JPRN-UMIN000011832 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000011832 |
|---|---|
| Public title | A study about immunogenicity and safety of Phase 3 and 4 immunization with combined measles-rubella vaccine |
| Scientific title | A study about immunogenicity and safety of Phase 3 and 4 immunization with combined measles-rubella vaccine - A study about immunogenicity and safety of Phase 3 and 4 immunization with MR vaccine |
| Primary sponsor | Konan Kosei Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | measles and rubella |
| Registration date | Sep 23, 2013 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: